Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Central Nervous System Demyelination—A Novel Disease Entity?

2018/06/18 by Martin S. Weber, Tobias Derfuß, Wolfgang Brück · 1 citation
Medicine · Neuroscience · #Multiple Sclerosis Research Studies #Neurogenesis and neuroplasticity mechanisms #Peripheral Neuropathies and Disorders

paper · doi:10.1001/jamaneurol.2018.1055

openalex publication_date 2018/06/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/22

Abstract

This Viewpoint summarizes the current knowledge of the clinical, radiologic, and immunologic features of adult patients who are positive for anti–myelin oligodendrocyte glycoprotein and compares these individuals with patients with multiple sclerosis and patients with neuromyelitis optica.

Cited by

• Acute disseminated encephalomyelitis [wikipedia]

Related

• Neuromyelitis optica spectrum and myelin oligodendrocyte glycoprotein antibody‐related disseminated encephalomyelitis
• Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
• Fulminant demyelinating encephalomyelitis
• Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases
• Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports